What is Standex International's operating income?

Standex International's total operating income in 2026 was $193.58 million, based on the following breakdown: Total Gross Profit: $372.03 million Total Operating Expenses: $178.45 million

Standex International (SXI) Financials

$311.36 +1.94 (+0.63%)

As of 08/21/2026 03:58 PM Eastern

Compare

Annual Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	52	47	37	68	20	36	61	139	73	56	105
Consolidated Net Income / (Loss)	52	47	37	68	20	36	61	139	73	58	129
Net Income / (Loss) Continuing Operations	52	39	30	48	41	39	61	139	74	58	129
Total Pre-Tax Income	69	51	68	67	54	53	81	164	95	69	163
Total Operating Income	70	57	78	79	61	59	88	171	102	94	194
Total Gross Profit	252	216	226	235	215	241	270	285	282	315	372
Total Revenue	752	648	596	640	605	656	735	741	721	790	892
Operating Revenue	752	648	596	640	605	656	735	741	721	790	892
Total Cost of Revenue	499	432	370	405	389	415	465	456	439	475	520
Operating Cost of Revenue	499	432	370	405	389	415	465	456	439	475	520
Total Operating Expenses	182	159	148	155	155	182	182	114	180	222	178
Selling, General & Admin Expense	170	145	141	150	148	163	170	172	170	193	219
Other Operating Expenses / (Income)	7.46	0.00	0.00	0.50	0.00	0.00	5.75	-63	-0.16	0.00	-57
Restructuring Charge	4.23	14	7.18	4.36	6.43	4.41	6.02	4.39	11	28	16
Total Other Income / (Expense), net	-1.82	-5.96	-9.75	-13	-6.45	-6.47	-7.01	-7.14	-6.62	-25	-31
Interest Expense	2.87	4.04	8.03	11	7.48	5.99	5.87	5.41	4.54	24	31
Other Income / (Expense), net	1.05	-1.92	-1.72	-1.74	1.02	-0.47	-1.13	-1.74	-2.07	-0.81	0.07
Income Tax Expense	16	12	38	19	13	14	20	25	22	11	34
Net Income / (Loss) Discontinued Operations	-0.17	7.41	6.24	20	-21	-2.07	-0.09	-0.16	-0.52	-0.04	-0.14
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	0.00	0.00	1.92	24
Basic Earnings per Share	$4.11	$3.68	$2.88	$5.40	$1.64	$3.00	$5.13	$11.77	$6.22	$4.68	$8.69
Weighted Average Basic Shares Outstanding	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M
Diluted Earnings per Share	$4.08	$3.65	$2.86	$5.38	$1.63	$2.97	$5.06	$11.58	$6.14	$4.64	$8.67
Weighted Average Diluted Shares Outstanding	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M
Weighted Average Basic & Diluted Shares Outstanding	12.68M	12.67M	12.70M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M

This table shows Standex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	19	16	20	18	0.86	22	15	15	2.12	67	20
Consolidated Net Income / (Loss)	19	16	20	18	1.28	23	15	16	21	69	24
Net Income / (Loss) Continuing Operations	19	16	20	18	1.29	23	15	16	21	69	24
Total Pre-Tax Income	24	20	26	23	2.00	18	26	21	27	83	32
Total Operating Income	26	22	27	24	8.46	26	35	30	36	91	38
Total Gross Profit	72	68	69	70	71	82	91	90	92	92	97
Total Revenue	178	177	180	170	190	208	222	217	221	225	228
Operating Revenue	178	177	180	170	190	208	222	217	221	225	228
Total Cost of Revenue	107	109	111	100	118	125	131	127	129	133	131
Operating Cost of Revenue	107	109	111	100	118	125	131	127	129	133	131
Total Operating Expenses	46	46	42	46	63	56	57	61	57	1.11	60
Selling, General & Admin Expense	43	42	41	43	46	52	53	54	56	52	57
Restructuring Charge	2.56	4.57	1.29	2.93	17	4.13	3.96	6.43	1.06	5.50	3.26
Total Other Income / (Expense), net	-1.35	-1.58	-1.57	-0.95	-6.47	-8.67	-8.65	-8.65	-8.40	-8.16	-5.44
Interest Expense	1.02	0.95	1.30	0.98	5.58	8.36	9.02	8.91	7.91	7.33	6.56
Other Income / (Expense), net	-0.33	-0.63	-0.27	0.03	-0.89	-0.31	0.36	0.27	-0.49	-0.83	1.12
Income Tax Expense	5.41	4.33	5.89	4.96	0.71	-5.20	11	5.17	6.54	14	8.52
Net Income / (Loss) Discontinued Operations	-0.20	-0.14	-0.10	0.01	-0.01	-0.05	0.01	-0.03	0.05	-0.12	-0.05
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	-	0.00	0.42	0.85	-	0.74	19	1.54	3.07
Basic Earnings per Share	$1.60	$1.34	$1.68	$1.54	$0.07	$1.83	$1.24	$1.26	$0.17	$5.56	$1.70
Weighted Average Basic Shares Outstanding	11.79M	11.77M	11.85M	11.79M	11.94M	11.99M	12.07M	12.01M	12.04M	12.05M	12.12M
Diluted Earnings per Share	$1.59	$1.33	$1.64	$1.53	$0.07	$1.81	$1.23	$1.25	$0.17	$5.55	$1.70
Weighted Average Diluted Shares Outstanding	11.86M	11.85M	11.85M	11.90M	12.03M	12.06M	12.07M	12.05M	12.06M	12.06M	12.12M
Weighted Average Basic & Diluted Shares Outstanding	11.87M	11.85M	11.85M	12.08M	11.90M	12.07M	12.07M	12.12M	12.12M	12.11M	12.12M

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Change in Cash & Equivalents	26	-33	21	-16	26	18	-32	91	-42	-50	74
Net Cash From Operating Activities	80	63	65	73	47	84	78	91	93	70	90
Net Cash From Continuing Operating Activities	81	51	52	73	55	82	78	91	93	70	90
Net Income / (Loss) Continuing Operations	52	39	30	48	41	39	61	139	74	58	129
Consolidated Net Income / (Loss)	52	47	37	68	20	36	61	139	73	58	129
Net Income / (Loss) Discontinued Operations	-0.17	7.41	6.24	20	-21	-2.07	-0.09	-0.16	-0.52	-0.04	-0.14
Depreciation Expense	18	18	25	29	32	33	30	28	28	35	39
Non-Cash Adjustments To Reconcile Net Income	14	6.44	3.04	4.02	6.11	22	12	-51	9.69	8.58	-47
Changes in Operating Assets and Liabilities, net	-3.04	-13	-6.46	-8.89	-25	-12	-25	-26	-18	-32	-31
Net Cash From Discontinued Operating Activities	-0.90	13	13	0.42	-7.44	1.72	-0.42	0.03	-0.69	-0.05	-0.35
Net Cash From Investing Activities	-29	-179	-32	-50	-0.62	-39	-31	42	-62	-503	43
Net Cash From Continuing Investing Activities	-32	-178	-29	-158	-21	-39	-31	42	-62	-503	43
Purchase of Property, Plant & Equipment	-18	-25	-24	-33	-22	-22	-24	-24	-20	-28	-25
Acquisitions	-14	-154	-10	-128	-0.62	-27	-13	0.00	-49	-479	0.00
Divestitures	-	-	-	0.00	0.00	12	0.00	67	7.77	0.00	68
Other Investing Activities, net	-0.42	0.11	1.82	-0.38	1.34	-1.73	4.01	-2.93	-0.27	3.80	0.01
Net Cash From Discontinued Investing Activities	2.80	-0.99	-2.97	108	20	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-21	85	-12	-38	-19	-32	-69	-40	-69	380	-57
Net Cash From Continuing Financing Activities	-21	85	-12	-38	-19	-32	-69	-40	-69	380	-57
Repayment of Debt	-75	-164	-165	-237	-105	-17	-25	-226	-25	-389	-110
Repurchase of Common Equity	-5.64	-7.81	-2.65	-33	-10	-21	-31	-26	-32	-9.91	-4.40
Payment of Dividends	-6.85	-7.85	-8.89	-9.83	-11	-11	-12	-13	-14	-15	-19
Issuance of Debt	65	264	164	242	107	17	0.00	225	0.00	792	75
Other Financing Activities, net	0.80	0.00	0.00	-0.91	-0.87	-0.36	-2.17	-1.17	1.53	2.23	1.69
Other Net Changes in Cash	-	-	0.29	-	-1.98	4.80	-	-	-3.33	3.69	-1.84
Cash Interest Paid	2.35	3.26	6.18	9.47	6.32	4.90	4.75	4.23	4.09	21	31
Cash Income Taxes Paid	25	20	22	24	19	17	18	26	28	28	38

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	16	-3.63	15	10	-43	-11	-5.27	-5.89	-1.66	6.73	75
Net Cash From Operating Activities	24	24	29	18	9.06	9.54	33	17	21	12	40
Net Cash From Continuing Operating Activities	24	24	29	18	9.12	9.55	33	17	21	12	40
Net Income / (Loss) Continuing Operations	19	16	20	18	1.29	23	15	16	21	69	24
Consolidated Net Income / (Loss)	19	16	20	18	1.28	23	15	16	21	69	24
Net Income / (Loss) Discontinued Operations	-0.20	-0.14	-0.10	0.01	-0.01	-0.05	0.01	-0.03	0.05	-0.12	-0.05
Depreciation Expense	6.89	7.18	6.99	7.06	8.51	9.74	10	9.82	9.98	9.45	9.40
Non-Cash Adjustments To Reconcile Net Income	-13	4.25	0.54	-4.32	0.71	-22	34	-7.55	-8.40	-64	33
Changes in Operating Assets and Liabilities, net	10	-2.92	1.51	-3.38	-1.39	-1.39	-26	-1.29	-1.51	-2.56	-25
Net Cash From Discontinued Operating Activities	-0.20	-0.08	-0.19	0.03	-0.06	-0.01	-0.01	0.02	-0.15	-0.16	-0.06
Net Cash From Investing Activities	-4.25	-16	-7.67	-6.31	-423	-64	-10	-6.36	-7.73	62	-5.11
Net Cash From Continuing Investing Activities	-4.25	-16	-7.67	-6.31	-423	-64	-10	-6.36	-7.73	62	-5.11
Purchase of Property, Plant & Equipment	-4.25	-5.18	-6.53	-6.73	-6.97	-6.07	-8.58	-6.42	-7.66	-5.59	-5.53
Divestitures	-	7.50	-	-	-	-	-	-	-	-	-0.02
Other Investing Activities, net	-	-0.27	-	0.41	3.49	-0.10	-0.44	0.06	-0.06	-0.42	0.44
Net Cash From Financing Activities	-7.62	-8.53	-3.37	-6.27	376	41	-31	-15	-15	-67	40
Net Cash From Continuing Financing Activities	-7.62	-8.53	-3.37	-6.27	376	41	-31	-15	-15	-67	40
Repayment of Debt	-	-	-	0.00	-339	-23	-27	-8.00	-18	-79	-5.00
Repurchase of Common Equity	-4.49	-5.13	-0.04	-4.38	-5.20	-	-0.32	-3.74	-0.06	-0.00	-0.60
Payment of Dividends	-3.55	-3.54	-3.53	-3.53	-3.83	-3.84	-3.84	-4.56	-4.97	-4.93	-4.45
Issuance of Debt	-	-	-	-	-	68	-	-	-	17	50
Other Financing Activities, net	-	-	-	1.64	-	-	-	0.81	0.39	0.25	0.24
Other Net Changes in Cash	-	-	-	5.40	-5.70	1.64	2.35	-0.86	0.15	-0.63	-0.50
Cash Interest Paid	0.94	0.86	1.01	0.90	2.66	9.68	7.92	8.73	7.90	7.51	6.55
Cash Income Taxes Paid	8.89	5.73	8.23	5.48	0.77	11	11	5.72	10	10	12

This table presents Standex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Total Assets	690	868	917	922	931	962	934	1,025	1,005	1,567	1,586
Total Current Assets	356	361	384	334	332	374	379	483	430	481	552
Cash & Equivalents	122	89	110	93	119	136	105	196	154	105	179
Accounts Receivable	104	127	120	103	98	110	117	123	121	173	173
Inventories, net	105	119	104	76	85	92	105	99	87	130	129
Prepaid Expenses	4.78	8.40	10	22	19	24	45	34	22	14	27
Other Current Assets	-	-	-	-	-	-	-	31	45	59	44
Plant, Property, & Equipment, net	107	133	137	134	133	133	129	131	135	160	153
Total Noncurrent Assets	228	374	396	454	466	454	427	411	440	926	881
Goodwill	157	243	212	274	271	278	268	265	281	610	582
Intangible Assets	40	103	85	119	106	99	86	76	79	226	199
Noncurrent Deferred & Refundable Income Taxes	11	1.14	7.45	14	17	9.57	8.19	15	17	12	4.41
Other Noncurrent Operating Assets	19	27	30	25	71	68	65	56	63	78	95
Total Liabilities & Shareholders' Equity	690	868	917	922	931	962	934	1,025	1,005	1,567	1,586
Total Liabilities	320	459	466	458	469	456	435	417	384	827	830
Total Current Liabilities	134	160	161	142	123	144	151	141	128	167	230
Accounts Payable	77	96	79	54	55	75	75	69	63	88	80
Accrued Expenses	51	59	58	50	60	62	68	62	57	63	68
Current Deferred & Payable Income Tax Liabilities	4.70	4.78	6.05	5.74	7.43	7.24	8.48	10	7.50	16	17
Other Current Liabilities	-	-	-	-	-	-	-	-	-	0.00	64
Total Noncurrent Liabilities	186	299	305	316	346	312	284	277	256	660	601
Long-Term Debt	92	192	194	198	199	199	175	173	149	553	518
Other Noncurrent Operating Liabilities	10	11	26	0.00	147	113	109	103	107	108	83
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	0.00	28	0.00
Total Equity & Noncontrolling Interests	370	409	451	464	462	506	499	607	622	712	755
Total Preferred & Common Equity	370	409	451	464	462	506	499	607	622	712	755
Total Common Equity	370	409	451	464	462	506	499	607	622	712	755
Common Stock	94	99	103	107	115	123	133	143	148	178	170
Retained Earnings	678	717	761	818	828	852	901	1,027	1,086	1,127	1,215
Treasury Stock	-284	-291	-292	-324	-333	-353	-382	-404	-430	-428	-431
Accumulated Other Comprehensive Income / (Loss)	-118	-116	-122	-137	-148	-116	-153	-158	-183	-165	-199

This table presents Standex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	957	1,015	981	1,005	994	1,038	1,483	1,555	1,555	1,555	1,527
Total Current Assets	401	461	420	436	419	447	465	487	488	491	483
Cash & Equivalents	113	175	127	142	139	165	121	110	99	97	104
Accounts Receivable	120	121	127	126	121	119	153	170	167	177	180
Inventories, net	106	105	98	99	95	90	104	120	136	131	130
Prepaid Expenses	49	57	67	66	62	24	31	29	22	23	26
Other Current Assets	-	-	-	-	-	50	56	58	64	63	43
Plant, Property, & Equipment, net	130	131	129	133	135	138	138	147	160	160	153
Total Noncurrent Assets	426	424	432	436	439	452	880	921	908	903	891
Goodwill	270	269	275	280	282	292	587	611	600	594	586
Intangible Assets	82	80	84	83	82	79	208	227	218	212	205
Noncurrent Deferred & Refundable Income Taxes	7.40	9.21	14	14	15	19	22	17	12	12	9.79
Other Noncurrent Operating Assets	63	65	59	59	60	62	64	67	78	86	91
Total Liabilities & Shareholders' Equity	957	1,015	981	1,005	994	1,038	1,483	1,555	1,555	1,555	1,527
Total Liabilities	427	410	387	384	375	380	800	840	820	810	728
Total Current Liabilities	132	131	132	131	122	126	138	143	170	171	158
Accounts Payable	66	68	62	64	58	67	73	76	88	88	77
Accrued Expenses	53	56	60	56	55	53	60	59	67	69	64
Current Deferred & Payable Income Tax Liabilities	9.78	7.37	9.90	11	8.45	6.61	5.18	7.17	15	14	17
Total Noncurrent Liabilities	295	279	255	254	252	254	662	697	650	639	570
Long-Term Debt	188	173	149	149	149	149	534	579	545	535	473
Other Noncurrent Operating Liabilities	107	106	107	105	103	105	128	118	106	104	97
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	27	28	27	45	44
Total Equity & Noncontrolling Interests	529	606	595	621	619	658	656	687	708	700	754
Total Preferred & Common Equity	529	606	595	621	619	658	656	687	708	700	754
Total Common Equity	529	606	595	621	619	658	656	687	708	700	754
Common Stock	135	139	141	143	147	150	174	177	179	182	184
Retained Earnings	933	1,010	1,043	1,058	1,070	1,101	1,098	1,116	1,138	1,136	1,199
Treasury Stock	-392	-397	-421	-425	-430	-432	-428	-428	-431	-430	-430
Accumulated Other Comprehensive Income / (Loss)	-147	-147	-168	-156	-168	-161	-188	-178	-179	-188	-199

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	12,114,922.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	12,114,922.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	8.64
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.66%	-13.80%	-8.08%	7.46%	-5.53%	8.55%	12.05%	0.78%	-2.75%	9.64%	12.85%
EBITDA Growth	-6.89%	-18.51%	39.34%	5.49%	-12.31%	-2.04%	27.11%	69.29%	-35.39%	0.08%	81.23%
EBIT Growth	-9.94%	-22.96%	38.94%	1.72%	-20.82%	-4.64%	48.51%	94.30%	-41.15%	-7.20%	108.81%
NOPAT Growth	-6.06%	-18.47%	-20.63%	65.15%	-19.88%	-5.75%	54.33%	117.45%	-45.80%	-0.29%	94.81%
Net Income Growth	-4.91%	-10.59%	-21.36%	85.54%	-70.27%	80.67%	68.32%	126.40%	-47.43%	-21.06%	122.84%
EPS Growth	-4.45%	-10.54%	-21.64%	88.11%	-69.70%	82.21%	70.37%	128.85%	-46.98%	-24.43%	86.85%
Operating Cash Flow Growth	25.43%	-21.02%	2.34%	12.97%	-35.59%	76.92%	-7.02%	16.84%	2.04%	-24.89%	28.69%
Free Cash Flow Firm Growth	375.99%	-288.31%	171.97%	-134.13%	254.90%	-72.78%	401.11%	93.07%	-63.11%	-1,132.99%	149.91%
Invested Capital Growth	-4.22%	50.94%	-11.37%	19.61%	-0.59%	5.54%	-0.04%	2.78%	5.30%	92.73%	-7.84%
Revenue Q/Q Growth	-0.79%	-11.48%	-12.00%	64.22%	-18.74%	5.99%	1.14%	0.49%	-1.12%	5.59%	0.70%
EBITDA Q/Q Growth	-8.73%	-7.15%	11.96%	-3.00%	-8.56%	15.34%	-4.45%	5.10%	-1.36%	9.72%	1.24%
EBIT Q/Q Growth	-11.30%	-8.27%	14.07%	-6.71%	-12.86%	25.22%	-4.73%	6.07%	-1.54%	9.72%	1.88%
NOPAT Q/Q Growth	-8.01%	-4.64%	7.37%	5.94%	-14.11%	26.08%	-1.84%	4.60%	-0.29%	0.68%	4.31%
Net Income Q/Q Growth	-7.45%	4.38%	-4.01%	-0.33%	-34.34%	49.74%	-1.10%	5.22%	-0.78%	-6.64%	6.69%
EPS Q/Q Growth	-7.27%	4.29%	-4.03%	0.19%	-34.27%	0.00%	0.00%	3.67%	0.82%	-8.12%	5.73%
Operating Cash Flow Q/Q Growth	-10.08%	-2.09%	6.19%	18.72%	-35.90%	14.69%	-3.18%	13.81%	-11.41%	7.54%	8.49%
Free Cash Flow Firm Q/Q Growth	-9.21%	-36.08%	1,457.27%	-183.69%	-27.96%	-48.27%	70.49%	0.52%	-10.95%	-3.29%	50.79%
Invested Capital Q/Q Growth	-9.52%	-0.69%	-18.20%	-4.93%	-2.99%	0.85%	-4.07%	-3.05%	-2.03%	0.29%	-6.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.56%	33.27%	37.95%	36.67%	35.64%	36.76%	36.71%	38.47%	39.13%	39.90%	41.73%
EBITDA Margin	11.89%	11.24%	17.04%	16.72%	15.52%	14.01%	15.89%	26.70%	17.74%	16.22%	26.05%
Operating Margin	9.36%	8.79%	13.12%	12.42%	10.01%	9.02%	12.01%	23.09%	14.12%	11.84%	21.71%
EBIT Margin	9.50%	8.49%	12.83%	12.15%	10.18%	8.94%	11.85%	22.85%	13.83%	11.74%	21.72%
Profit (Net Income) Margin	6.93%	7.18%	6.15%	10.61%	3.34%	5.56%	8.35%	18.76%	10.14%	7.30%	14.42%
Tax Burden Percent	75.97%	91.34%	53.52%	101.40%	37.33%	69.21%	75.52%	84.78%	76.82%	83.83%	78.89%
Interest Burden Percent	95.98%	92.65%	89.49%	86.16%	87.86%	89.79%	93.26%	96.81%	95.44%	74.20%	84.14%
Effective Tax Rate	23.78%	23.20%	55.60%	27.90%	24.15%	26.86%	24.37%	15.12%	22.64%	16.11%	21.02%
Return on Invested Capital (ROIC)	15.46%	10.27%	7.18%	11.50%	8.48%	7.80%	11.73%	25.16%	13.10%	8.70%	13.40%
ROIC Less NNEP Spread (ROIC-NNEP)	27.91%	18.06%	10.77%	37.51%	-24.37%	-1.83%	3.63%	-0.92%	53.95%	-0.69%	7.21%
Return on Net Nonoperating Assets (RNNOA)	-0.97%	1.69%	1.33%	3.35%	-4.12%	-0.27%	0.48%	-0.04%	-1.21%	-0.23%	3.80%
Return on Equity (ROE)	14.49%	11.96%	8.52%	14.84%	4.36%	7.54%	12.21%	25.12%	11.89%	8.48%	17.20%
Cash Return on Invested Capital (CROIC)	19.77%	-30.33%	19.24%	-6.36%	9.08%	2.41%	11.77%	22.41%	7.94%	-54.65%	21.56%
Operating Return on Assets (OROA)	10.58%	7.06%	8.56%	8.45%	6.64%	6.20%	9.19%	17.29%	9.82%	7.21%	12.29%
Return on Assets (ROA)	7.71%	5.97%	4.10%	7.39%	2.18%	3.85%	6.47%	14.19%	7.20%	4.49%	8.15%
Return on Common Equity (ROCE)	14.49%	11.96%	8.52%	14.84%	4.36%	7.54%	12.21%	25.12%	11.89%	8.30%	16.88%
Return on Equity Simple (ROE_SIMPLE)	14.07%	11.39%	8.12%	14.63%	4.37%	7.20%	12.29%	22.88%	11.76%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	54	44	35	57	46	43	67	145	79	78	153
NOPAT Margin	7.13%	6.75%	5.83%	8.95%	7.59%	6.59%	9.08%	19.60%	10.92%	9.93%	17.15%
Net Nonoperating Expense Percent (NNEP)	-12.44%	-7.79%	-3.59%	-26.01%	32.86%	9.63%	8.09%	26.07%	-40.84%	9.40%	6.19%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	6.21%	12.01%
Cost of Revenue to Revenue	66.44%	66.73%	62.05%	63.33%	64.36%	63.24%	63.29%	61.53%	60.87%	60.10%	58.27%
SG&A Expenses to Revenue	22.65%	22.39%	23.62%	23.49%	24.56%	24.85%	23.10%	23.26%	23.53%	24.47%	24.60%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.20%	24.48%	24.83%	24.25%	25.63%	27.75%	24.70%	15.38%	25.01%	28.06%	20.01%
Earnings before Interest and Taxes (EBIT)	71	55	76	78	62	59	87	169	100	93	194
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	89	73	101	107	94	92	117	198	128	128	232
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.65	2.64	2.73	1.89	1.49	2.24	2.01	2.75	3.07	2.65	5.73
Price to Tangible Book Value (P/TBV)	5.69	16.97	7.99	12.21	8.17	8.75	6.91	6.26	7.29	0.00	0.00
Price to Revenue (P/Rev)	1.30	1.66	2.07	1.37	1.14	1.73	1.37	2.26	2.65	2.39	4.86
Price to Earnings (P/E)	18.81	23.14	33.62	12.91	33.99	31.05	16.38	12.03	26.09	33.88	41.37
Dividend Yield	0.71%	0.73%	0.73%	1.13%	1.56%	1.02%	1.22%	0.78%	0.55%	0.81%	0.38%
Earnings Yield	5.32%	4.32%	2.97%	7.74%	2.94%	3.22%	6.10%	8.31%	3.83%	2.95%	2.42%
Enterprise Value to Invested Capital (EV/IC)	2.80	2.31	2.90	1.81	1.42	2.10	1.89	2.82	3.09	1.99	4.27
Enterprise Value to Revenue (EV/Rev)	1.26	1.82	2.21	1.53	1.27	1.82	1.46	2.23	2.64	2.99	5.24
Enterprise Value to EBITDA (EV/EBITDA)	10.62	16.21	12.96	9.17	8.17	13.01	9.21	8.34	14.88	18.45	20.09
Enterprise Value to EBIT (EV/EBIT)	13.29	21.46	17.21	12.62	12.45	20.37	12.34	9.74	19.08	25.50	24.11
Enterprise Value to NOPAT (EV/NOPAT)	17.70	27.00	37.90	17.13	16.70	27.63	16.11	11.36	24.16	30.13	30.53
Enterprise Value to Operating Cash Flow (EV/OCF)	11.82	18.61	20.25	13.38	16.23	14.30	13.84	18.17	20.52	33.98	52.12
Enterprise Value to Free Cash Flow (EV/FCFF)	13.84	0.00	14.15	0.00	15.60	89.42	16.06	12.75	39.85	0.00	18.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.25	0.47	0.43	0.43	0.43	0.39	0.35	0.29	0.24	0.75	0.69
Long-Term Debt to Equity	0.25	0.47	0.43	0.43	0.43	0.39	0.35	0.29	0.24	0.75	0.69
Financial Leverage	-0.03	0.09	0.12	0.09	0.17	0.15	0.13	0.04	-0.02	0.33	0.53
Leverage Ratio	1.88	2.00	2.08	2.01	2.00	1.96	1.89	1.77	1.65	1.89	2.11
Compound Leverage Factor	1.80	1.85	1.86	1.73	1.76	1.76	1.76	1.71	1.58	1.40	1.77
Debt to Total Capital	19.93%	31.96%	30.06%	29.85%	30.14%	28.26%	25.93%	22.21%	19.33%	42.76%	40.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.93%	31.96%	30.06%	29.85%	30.14%	28.26%	25.93%	22.21%	19.33%	42.76%	40.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.16%	0.00%
Common Equity to Total Capital	80.07%	68.04%	69.94%	70.15%	69.86%	71.74%	74.07%	77.79%	80.68%	55.08%	59.32%
Debt to EBITDA	1.03	2.64	1.91	1.85	2.12	2.17	1.50	0.88	1.16	4.31	2.23
Net Debt to EBITDA	-0.33	1.42	0.83	0.98	0.86	0.69	0.60	-0.11	-0.04	3.49	1.46
Long-Term Debt to EBITDA	1.03	2.64	1.91	1.85	2.12	2.17	1.50	0.88	1.16	4.31	2.23
Debt to NOPAT	1.72	4.39	5.58	3.45	4.34	4.61	2.62	1.19	1.89	7.04	3.39
Net Debt to NOPAT	-0.56	2.37	2.43	1.82	1.75	1.46	1.05	-0.15	-0.07	5.71	2.22
Long-Term Debt to NOPAT	1.72	4.39	5.58	3.45	4.34	4.61	2.62	1.19	1.89	7.04	3.39
Altman Z-Score	5.02	3.80	3.96	3.62	3.26	3.90	4.13	5.47	5.90	3.32	5.41
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.05%	1.87%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.65	2.26	2.38	2.36	2.70	2.61	2.51	3.43	3.37	2.88	2.40
Quick Ratio	1.68	1.35	1.42	1.39	1.77	1.71	1.47	2.26	2.16	1.66	1.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	69	-129	93	-32	49	13	67	129	48	-493	246
Operating Cash Flow to CapEx	459.84%	260.52%	313.42%	249.96%	221.37%	386.33%	352.12%	403.06%	456.48%	249.40%	355.42%
Free Cash Flow to Firm to Interest Expense	23.88	-31.93	11.57	-2.95	6.57	2.23	11.41	23.93	10.50	-20.60	8.01
Operating Cash Flow to Interest Expense	27.98	15.69	8.09	6.82	6.32	13.95	13.23	16.80	20.39	2.91	2.92
Operating Cash Flow Less CapEx to Interest Expense	21.89	9.67	5.51	4.09	3.47	10.34	9.47	12.63	15.92	1.74	2.10
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	0.83	0.67	0.70	0.65	0.69	0.78	0.76	0.71	0.61	0.57
Accounts Receivable Turnover	7.01	5.61	4.83	5.74	6.00	6.31	6.48	6.16	5.89	5.37	5.16
Inventory Turnover	4.67	3.85	3.30	4.49	4.82	4.69	4.72	4.47	4.73	4.37	4.01
Fixed Asset Turnover	6.98	5.40	4.41	4.72	4.53	4.94	5.61	5.71	5.42	5.35	5.69
Accounts Payable Turnover	6.33	4.98	4.21	6.09	7.13	6.40	6.24	6.37	6.65	6.27	6.18
Days Sales Outstanding (DSO)	52.07	65.08	75.65	63.64	60.84	57.86	56.33	59.23	62.00	67.92	70.74
Days Inventory Outstanding (DIO)	78.11	94.90	110.48	81.33	75.67	77.80	77.33	81.60	77.24	83.44	90.96
Days Payable Outstanding (DPO)	57.70	73.28	86.65	59.96	51.18	57.03	58.54	57.29	54.91	58.17	59.05
Cash Conversion Cycle (CCC)	72.48	86.70	99.49	85.01	85.33	78.63	75.12	83.55	84.33	93.19	102.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	339	512	454	543	540	570	569	585	616	1,188	1,094
Invested Capital Turnover	2.17	1.52	1.23	1.28	1.12	1.18	1.29	1.28	1.20	0.88	0.78
Increase / (Decrease) in Invested Capital	-15	173	-58	89	-3.22	30	-0.22	16	31	571	-93
Enterprise Value (EV)	949	1,180	1,315	981	767	1,196	1,076	1,650	1,901	2,365	4,668
Market Capitalization	979	1,077	1,231	877	686	1,132	1,006	1,672	1,907	1,889	4,329
Book Value per Share	$28.89	$32.06	$35.13	$36.70	$37.20	$41.30	$41.37	$51.03	$52.43	$58.95	$62.34
Tangible Book Value per Share	$13.45	$4.98	$12.01	$5.68	$6.77	$10.56	$12.07	$22.43	$22.07	($10.31)	($2.13)
Total Capital	462	601	645	662	661	706	674	781	770	1,292	1,273
Total Debt	92	192	194	198	199	199	175	173	149	553	518
Total Long-Term Debt	92	192	194	198	199	199	175	173	149	553	518
Net Debt	-30	103	84	104	80	63	70	-22	-5.33	448	339
Capital Expenditures (CapEx)	17	24	21	29	21	22	22	23	20	28	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	100	112	113	99	90	94	123	147	148	209	144
Debt-free Net Working Capital (DFNWC)	222	201	223	192	209	231	228	342	303	314	322
Net Working Capital (NWC)	222	201	223	192	209	231	228	342	303	314	322
Net Nonoperating Expense (NNE)	1.56	-2.83	-1.91	-11	26	6.80	5.39	6.22	5.63	21	24
Net Nonoperating Obligations (NNO)	-31	103	3.06	79	78	63	70	-22	-5.33	448	339
Total Depreciation and Amortization (D&A)	18	18	25	29	32	33	30	28	28	35	39
Debt-free, Cash-free Net Working Capital to Revenue	13.27%	17.34%	18.98%	15.49%	14.94%	14.37%	16.78%	19.78%	20.58%	26.50%	16.10%
Debt-free Net Working Capital to Revenue	29.50%	31.01%	37.38%	30.04%	34.59%	35.15%	31.04%	46.19%	41.98%	39.73%	36.14%
Net Working Capital to Revenue	29.50%	31.01%	37.38%	30.04%	34.59%	35.15%	31.04%	46.19%	41.98%	39.73%	36.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.11	$3.68	$2.88	$5.40	$1.64	$3.00	$5.13	$11.77	$6.22	$4.68	$8.69
Adjusted Weighted Average Basic Shares Outstanding	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M
Adjusted Diluted Earnings per Share	$4.08	$3.65	$2.86	$5.38	$1.63	$2.97	$5.06	$11.58	$6.14	$4.64	$8.67
Adjusted Weighted Average Diluted Shares Outstanding	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.78M	12.78M	12.83M	12.45M	12.38M	12.21M	11.97M	11.85M	11.85M	12.07M	12.12M
Normalized Net Operating Profit after Tax (NOPAT)	57	54	60	60	51	57	71	96	87	102	166
Normalized NOPAT Margin	7.56%	8.36%	10.03%	9.45%	8.40%	8.72%	9.70%	12.99%	12.06%	12.94%	18.59%
Pre Tax Income Margin	9.12%	7.87%	11.48%	10.47%	8.94%	8.03%	11.05%	22.12%	13.20%	8.71%	18.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	24.87	13.60	9.52	7.22	8.23	9.80	14.84	31.33	21.93	3.88	6.31
NOPAT to Interest Expense	18.68	10.81	4.32	5.33	6.14	7.22	11.37	26.87	17.32	3.28	4.98
EBIT Less CapEx to Interest Expense	18.78	7.58	6.94	4.50	5.38	6.18	11.08	27.16	17.47	2.71	5.48
NOPAT Less CapEx to Interest Expense	12.59	4.79	1.74	2.60	3.29	3.61	7.61	22.70	12.85	2.11	4.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	13.15%	16.87%	24.28%	14.47%	52.54%	31.39%	19.95%	9.34%	19.02%	26.06%	14.71%
Augmented Payout Ratio	23.98%	33.64%	31.53%	63.64%	104.24%	89.52%	71.14%	27.71%	62.57%	43.23%	18.14%

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	12,116,999.00	12,118,733.00	12,114,922.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	12,116,999.00	12,118,733.00	12,114,922.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	0.18	5.53	1.69
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.00%	-3.83%	-4.32%	-7.74%	6.40%	17.21%	23.23%	27.55%	16.60%	8.09%	2.79%
EBITDA Growth	-7.02%	-70.14%	-4.94%	-5.93%	-50.36%	25.70%	32.43%	27.34%	180.30%	178.65%	6.31%
EBIT Growth	-8.52%	-75.83%	-5.47%	-7.46%	-70.30%	22.29%	29.25%	23.92%	363.26%	246.89%	10.19%
NOPAT Growth	-5.19%	-79.20%	-1.14%	-7.68%	-72.89%	98.00%	-1.38%	18.00%	395.18%	121.69%	33.92%
Net Income Growth	-5.85%	-80.38%	-2.87%	-3.28%	-93.24%	43.85%	-20.95%	-13.20%	1,522.04%	201.49%	52.07%
EPS Growth	-5.92%	-80.35%	3.14%	-3.16%	-95.60%	36.09%	-25.00%	-18.30%	142.86%	206.63%	38.21%
Operating Cash Flow Growth	-20.77%	4.68%	-29.49%	8.61%	-61.56%	-60.85%	17.10%	-4.25%	126.96%	23.13%	20.97%
Free Cash Flow Firm Growth	-407.48%	-111.28%	-291.31%	17.80%	-3,192.43%	-6,275.87%	-5,353.96%	-7,137.84%	87.13%	117.65%	121.92%
Invested Capital Growth	5.77%	4.20%	5.30%	4.23%	74.83%	88.27%	92.73%	83.80%	7.91%	-1.40%	-7.84%
Revenue Q/Q Growth	-3.45%	-0.64%	1.65%	-5.40%	11.35%	9.47%	6.87%	-2.08%	1.79%	1.48%	1.63%
EBITDA Q/Q Growth	-2.31%	-12.34%	19.31%	-7.93%	-48.45%	121.97%	26.72%	-12.18%	13.47%	120.66%	-51.65%
EBIT Q/Q Growth	-2.19%	-16.80%	26.71%	-10.25%	-68.61%	242.59%	35.28%	-14.81%	17.34%	156.53%	-57.03%
NOPAT Q/Q Growth	-1.87%	-14.64%	21.62%	-9.38%	-71.19%	523.46%	-39.42%	8.42%	20.92%	179.12%	-63.40%
Net Income Q/Q Growth	0.30%	-16.28%	24.01%	-7.12%	-92.99%	1,682.43%	-31.86%	2.00%	30.93%	231.30%	-65.63%
EPS Q/Q Growth	0.63%	-16.35%	23.31%	-6.71%	-95.42%	2,485.71%	-32.04%	1.63%	-86.40%	3,164.71%	-69.37%
Operating Cash Flow Q/Q Growth	45.64%	3.40%	17.14%	-38.44%	-48.46%	5.32%	250.36%	-49.66%	22.18%	-42.86%	244.19%
Free Cash Flow Firm Q/Q Growth	-62.33%	41.95%	-23.55%	29.40%	-6,402.04%	-12.42%	-5.69%	6.31%	88.44%	254.20%	31.26%
Invested Capital Q/Q Growth	1.70%	0.34%	-2.03%	4.26%	70.58%	8.06%	0.29%	-0.57%	0.14%	-1.27%	-6.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.17%	38.52%	38.52%	41.11%	37.64%	39.67%	41.12%	41.59%	41.67%	40.93%	42.69%
EBITDA Margin	18.15%	16.02%	18.80%	18.30%	8.47%	17.18%	20.37%	18.27%	20.36%	44.28%	21.06%
Operating Margin	14.48%	12.32%	15.07%	14.14%	4.46%	12.64%	15.64%	13.63%	16.07%	40.44%	16.45%
EBIT Margin	14.29%	11.97%	14.92%	14.15%	3.99%	12.49%	15.81%	13.75%	15.85%	40.07%	16.94%
Profit (Net Income) Margin	10.58%	8.91%	10.87%	10.68%	0.67%	10.94%	6.97%	7.26%	9.34%	30.51%	10.32%
Tax Burden Percent	77.08%	77.95%	76.58%	78.60%	63.81%	129.26%	59.38%	75.26%	76.12%	82.88%	73.33%
Interest Burden Percent	96.00%	95.53%	95.16%	95.95%	26.38%	67.77%	74.31%	70.19%	77.44%	91.86%	83.04%
Effective Tax Rate	22.09%	21.35%	23.04%	21.43%	35.54%	-29.56%	40.68%	24.61%	24.06%	16.98%	26.51%
Return on Invested Capital (ROIC)	13.61%	11.46%	13.91%	12.46%	2.40%	13.51%	8.13%	9.43%	9.31%	25.28%	9.45%
ROIC Less NNEP Spread (ROIC-NNEP)	10.00%	-22.98%	23.35%	-11.60%	0.40%	8.80%	5.82%	6.39%	7.82%	23.64%	8.42%
Return on Net Nonoperating Assets (RNNOA)	0.60%	-0.15%	-0.52%	-0.06%	0.13%	3.17%	1.89%	1.98%	4.66%	13.10%	4.43%
Return on Equity (ROE)	14.22%	11.31%	13.39%	12.41%	2.52%	16.68%	10.02%	11.41%	13.97%	38.39%	13.88%
Cash Return on Invested Capital (CROIC)	18.11%	8.69%	7.94%	8.11%	-47.10%	-52.64%	-54.65%	-50.03%	1.41%	13.88%	21.56%
Operating Return on Assets (OROA)	10.72%	8.68%	10.59%	9.90%	2.30%	7.33%	9.71%	8.88%	9.07%	23.03%	9.58%
Return on Assets (ROA)	7.94%	6.47%	7.72%	7.47%	0.39%	6.42%	4.29%	4.69%	5.34%	17.53%	5.84%
Return on Common Equity (ROCE)	14.22%	11.31%	13.39%	12.41%	2.47%	16.33%	9.82%	11.19%	13.27%	36.56%	13.62%
Return on Equity Simple (ROE_SIMPLE)	22.30%	11.90%	0.00%	11.01%	8.36%	9.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	20	17	21	19	5.46	34	21	22	27	75	28
NOPAT Margin	11.28%	9.69%	11.59%	11.11%	2.87%	16.37%	9.28%	10.28%	12.21%	33.57%	12.09%
Net Nonoperating Expense Percent (NNEP)	3.61%	34.44%	-9.44%	24.07%	1.99%	4.71%	2.31%	3.04%	1.49%	1.64%	1.03%
Return On Investment Capital (ROIC_SIMPLE)	2.62%	-	-	-	0.46%	2.69%	1.63%	1.78%	2.19%	6.15%	2.17%
Cost of Revenue to Revenue	59.83%	61.48%	61.48%	58.89%	62.36%	60.33%	58.88%	58.41%	58.33%	59.07%	57.31%
SG&A Expenses to Revenue	24.26%	23.56%	22.74%	25.25%	24.06%	25.05%	23.69%	25.01%	25.12%	23.35%	24.92%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.69%	26.20%	23.46%	26.97%	33.18%	27.04%	25.47%	27.96%	25.60%	0.49%	26.24%
Earnings before Interest and Taxes (EBIT)	26	21	27	24	7.57	26	35	30	35	90	39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	32	28	34	31	16	36	45	40	45	99	48
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	3.48	3.07	3.29	3.44	2.80	2.65	3.61	0.00	4.10	5.73
Price to Tangible Book Value (P/TBV)	7.27	8.45	7.29	7.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.54	2.96	2.65	3.07	3.15	2.57	2.39	3.06	0.00	3.49	4.86
Price to Earnings (P/E)	13.53	29.27	26.09	29.90	41.50	31.73	33.88	48.60	0.00	31.20	41.37
Dividend Yield	0.71%	0.47%	0.55%	0.49%	0.65%	0.77%	0.81%	0.60%	0.60%	0.52%	0.38%
Earnings Yield	7.39%	3.42%	3.83%	3.34%	2.41%	3.15%	2.95%	2.06%	0.00%	3.20%	2.42%
Enterprise Value to Invested Capital (EV/IC)	3.00	3.44	3.09	3.35	2.46	2.04	1.99	2.57	0.00	3.00	4.27
Enterprise Value to Revenue (EV/Rev)	2.55	2.97	2.64	3.05	3.76	3.23	2.99	3.62	0.00	3.96	5.24
Enterprise Value to EBITDA (EV/EBITDA)	9.57	16.71	14.88	17.09	24.64	20.69	18.45	22.17	0.00	15.26	20.09
Enterprise Value to EBIT (EV/EBIT)	11.19	21.39	19.08	22.01	33.82	28.60	25.50	30.76	0.00	18.42	24.11
Enterprise Value to NOPAT (EV/NOPAT)	12.99	27.43	24.16	27.89	42.64	31.01	30.13	36.82	0.00	23.89	30.53
Enterprise Value to Operating Cash Flow (EV/OCF)	18.14	20.70	20.52	22.87	33.93	37.35	33.98	44.02	0.00	42.42	52.12
Enterprise Value to Free Cash Flow (EV/FCFF)	17.01	40.41	39.85	42.12	0.00	0.00	0.00	0.00	0.00	21.46	18.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.24	0.24	0.24	0.23	0.78	0.81	0.75	0.74	0.72	0.59	0.69
Long-Term Debt to Equity	0.24	0.24	0.24	0.23	0.78	0.81	0.75	0.74	0.72	0.59	0.69
Financial Leverage	0.06	0.01	-0.02	0.00	0.32	0.36	0.33	0.31	0.60	0.55	0.53
Leverage Ratio	1.71	1.64	1.65	1.61	1.91	1.91	1.89	1.86	2.13	2.04	2.11
Compound Leverage Factor	1.64	1.57	1.57	1.55	0.50	1.29	1.40	1.31	1.65	1.87	1.75
Debt to Total Capital	19.33%	19.38%	19.33%	18.46%	43.90%	44.78%	42.76%	42.57%	41.79%	37.20%	40.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.33%	19.38%	19.33%	18.46%	43.90%	44.78%	42.76%	42.57%	41.79%	37.20%	40.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	2.19%	2.13%	2.16%	2.12%	3.48%	3.48%	0.00%
Common Equity to Total Capital	80.67%	80.62%	80.68%	81.54%	53.91%	53.09%	55.08%	55.31%	54.73%	59.33%	59.32%
Debt to EBITDA	0.76	1.15	1.16	1.18	4.88	4.96	4.31	3.98	3.23	2.06	2.23
Net Debt to EBITDA	0.03	0.08	-0.04	-0.12	3.77	4.02	3.49	3.26	2.64	1.61	1.46
Long-Term Debt to EBITDA	0.76	1.15	1.16	1.18	4.88	4.96	4.31	3.98	3.23	2.06	2.23
Debt to NOPAT	1.03	1.88	1.89	1.93	8.44	7.43	7.04	6.62	5.21	3.23	3.39
Net Debt to NOPAT	0.04	0.13	-0.07	-0.20	6.53	6.02	5.71	5.42	4.26	2.52	2.22
Long-Term Debt to NOPAT	1.03	1.88	1.89	1.93	8.44	7.43	7.04	6.62	5.21	3.23	3.39
Altman Z-Score	5.57	6.12	5.66	6.04	3.50	3.18	3.20	3.74	0.00	4.67	5.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	2.04%	2.07%	2.05%	1.95%	4.98%	4.75%	1.87%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.34	3.43	3.37	3.55	3.37	3.40	2.88	2.87	2.87	3.05	2.40
Quick Ratio	2.05	2.12	2.16	2.25	1.99	1.95	1.66	1.56	1.60	1.79	1.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-14	-8.17	-10	-7.13	-464	-521	-551	-516	-60	92	121
Operating Cash Flow to CapEx	554.60%	470.59%	436.92%	261.31%	130.05%	157.11%	389.51%	262.09%	268.24%	210.14%	731.80%
Free Cash Flow to Firm to Interest Expense	-13.82	-8.61	-7.77	-7.30	-83.15	-62.31	-61.09	-57.90	-7.54	12.55	18.41
Operating Cash Flow to Interest Expense	23.13	25.68	21.96	17.99	1.62	1.14	3.71	1.89	2.60	1.60	6.17
Operating Cash Flow Less CapEx to Interest Expense	18.96	20.22	16.93	11.10	0.38	0.41	2.76	1.17	1.63	0.84	5.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.75	0.73	0.71	0.70	0.58	0.59	0.61	0.65	0.57	0.57	0.57
Accounts Receivable Turnover	6.00	6.03	5.89	5.75	5.15	5.15	5.37	5.87	5.27	5.07	5.16
Inventory Turnover	4.38	4.43	4.73	4.53	4.33	4.23	4.37	4.44	4.36	4.16	4.01
Fixed Asset Turnover	5.61	5.49	5.42	5.28	5.31	5.31	5.35	5.62	5.83	5.92	5.69
Accounts Payable Turnover	6.87	7.03	6.65	6.64	6.39	6.74	6.27	6.50	6.36	6.75	6.18
Days Sales Outstanding (DSO)	60.88	60.52	62.00	63.53	70.88	70.82	67.92	62.22	69.30	72.05	70.74
Days Inventory Outstanding (DIO)	83.40	82.35	77.24	80.55	84.31	86.31	83.44	82.21	83.80	87.66	90.96
Days Payable Outstanding (DPO)	53.16	51.94	54.91	54.97	57.13	54.14	58.17	56.12	57.42	54.05	59.05
Cash Conversion Cycle (CCC)	91.13	90.92	84.33	89.11	98.05	103.00	93.19	88.31	95.67	105.67	102.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	627	629	616	642	1,096	1,184	1,188	1,181	1,182	1,168	1,094
Invested Capital Turnover	1.21	1.18	1.20	1.12	0.83	0.83	0.88	0.92	0.76	0.75	0.78
Increase / (Decrease) in Invested Capital	34	25	31	26	469	555	571	538	87	-17	-93
Enterprise Value (EV)	1,878	2,165	1,901	2,151	2,699	2,417	2,365	3,030	0.00	3,502	4,668
Market Capitalization	1,872	2,155	1,907	2,167	2,259	1,920	1,889	2,557	0.00	3,089	4,329
Book Value per Share	$52.15	$52.14	$52.43	$55.51	$54.30	$57.73	$58.95	$58.91	$58.14	$62.23	$62.34
Tangible Book Value per Share	$21.64	$21.49	$22.07	$24.20	($11.44)	($12.66)	($10.31)	($9.19)	($8.79)	($2.99)	($2.13)
Total Capital	769	768	770	807	1,217	1,294	1,292	1,279	1,279	1,271	1,273
Total Debt	149	149	149	149	534	579	553	545	535	473	518
Total Long-Term Debt	149	149	149	149	534	579	553	545	535	473	518
Net Debt	6.24	9.97	-5.33	-16	413	470	448	446	438	369	339
Capital Expenditures (CapEx)	4.25	5.18	6.53	6.73	6.97	6.07	8.58	6.42	7.66	5.59	5.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	163	158	148	157	206	234	209	219	223	221	144
Debt-free Net Working Capital (DFNWC)	305	297	303	321	327	344	314	318	320	324	322
Net Working Capital (NWC)	305	297	303	321	327	344	314	318	320	324	322
Net Nonoperating Expense (NNE)	1.25	1.38	1.30	0.74	4.18	11	5.12	6.55	6.33	6.89	4.04
Net Nonoperating Obligations (NNO)	6.24	9.97	-5.33	-16	413	470	448	446	438	369	339
Total Depreciation and Amortization (D&A)	6.89	7.18	6.99	7.06	8.51	9.74	10	9.82	9.98	9.45	9.40
Debt-free, Cash-free Net Working Capital to Revenue	22.16%	21.68%	20.58%	22.17%	28.65%	31.27%	26.50%	26.19%	25.67%	24.91%	16.10%
Debt-free Net Working Capital to Revenue	41.51%	40.73%	41.98%	45.47%	45.53%	45.95%	39.73%	37.97%	36.83%	36.63%	36.14%
Net Working Capital to Revenue	41.51%	40.73%	41.98%	45.47%	45.53%	45.95%	39.73%	37.97%	36.83%	36.63%	36.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.60	$1.34	$1.68	$1.54	$0.07	$1.83	$1.24	$1.26	$0.17	$5.56	$1.70
Adjusted Weighted Average Basic Shares Outstanding	11.79M	11.77M	11.85M	11.79M	11.94M	11.99M	12.07M	12.01M	12.04M	12.05M	12.12M
Adjusted Diluted Earnings per Share	$1.59	$1.33	$1.64	$1.53	$0.07	$1.81	$1.23	$1.25	$0.17	$5.55	$1.70
Adjusted Weighted Average Diluted Shares Outstanding	11.86M	11.85M	11.85M	11.90M	12.03M	12.06M	12.07M	12.05M	12.06M	12.06M	12.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.87M	11.85M	11.85M	12.08M	11.90M	12.07M	12.07M	12.12M	12.12M	12.11M	12.12M
Normalized Net Operating Profit after Tax (NOPAT)	22	21	22	21	17	21	23	27	28	80	30
Normalized NOPAT Margin	12.40%	11.72%	12.15%	12.46%	8.76%	10.24%	10.34%	12.50%	12.57%	35.61%	13.14%
Pre Tax Income Margin	13.72%	11.43%	14.20%	13.58%	1.05%	8.46%	11.75%	9.65%	12.28%	36.81%	14.07%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	25.02	22.36	20.68	24.70	1.36	3.10	3.89	3.35	4.43	12.28	5.90
NOPAT to Interest Expense	19.75	18.10	16.07	19.38	0.98	4.07	2.29	2.51	3.41	10.29	4.21
EBIT Less CapEx to Interest Expense	20.85	16.90	15.65	17.81	0.11	2.38	2.94	2.63	3.46	11.52	5.05
NOPAT Less CapEx to Interest Expense	15.58	12.65	11.05	12.50	-0.27	3.34	1.33	1.79	2.45	9.53	3.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	9.70%	18.55%	19.02%	19.52%	26.29%	23.83%	26.06%	29.06%	23.03%	15.19%	14.71%
Augmented Payout Ratio	37.64%	71.13%	62.57%	38.91%	53.19%	39.41%	43.23%	45.82%	28.55%	18.61%	18.14%

Financials Breakdown Chart

Key Financial Trends

Standex International’s recent results show a business that has expanded its revenue base and improved gross profitability, although earnings and cash flow remain uneven. The latest quarter, Q4 fiscal 2026, produced $228.3 million in revenue, up from $184.7 million in Q4 fiscal 2022 and $222.0 million in Q4 fiscal 2025. This represents roughly 24% growth over the four-year comparison and about 3% year over year.

Profitability has generally improved. Q4 fiscal 2026 gross profit was $97.4 million, equal to a 42.7% gross margin, compared with 36.0% in Q4 fiscal 2022 and 41.1% in Q4 fiscal 2025. Operating income reached $37.6 million, or a 16.4% operating margin, versus $19.2 million, or 10.4%, in Q4 fiscal 2022. However, the unusually high $90.8 million operating profit reported in Q3 fiscal 2026 was influenced by a $56.8 million negative “other operating expenses” entry, so investors should avoid treating that quarter as a normal run rate.

Net income attributable to common shareholders was $20.5 million in Q4 fiscal 2026, or $1.70 per diluted share. That compares favorably with $14.8 million and $1.23 per share in Q4 fiscal 2025. Still, quarterly earnings have been volatile, including only $2.1 million of common earnings in Q2 fiscal 2026 because of a $18.6 million allocation to noncontrolling interests.

Revenue has moved higher: Quarterly revenue increased from approximately $180 million-$189 million in fiscal 2022-2024 to more than $217 million in each fiscal 2026 quarter, reaching $228.3 million in Q4 fiscal 2026.
Gross margins have expanded: The latest 42.7% gross margin is materially above the roughly 36%-38% range reported in several earlier comparison quarters, suggesting a more favorable product mix, pricing, or operating efficiency.
Core operating profitability is stronger: Q4 fiscal 2026 operating income of $37.6 million was more than double the Q4 fiscal 2022 level, despite a $3.3 million restructuring charge in the latest quarter.
Interest expense has declined from the recent peak: Quarterly interest expense fell to $6.6 million in Q4 fiscal 2026 from $9.0 million in Q4 fiscal 2025 and $8.9 million in Q1 fiscal 2026.
Operating cash flow remains positive: Standex generated $40.4 million of operating cash flow in Q4 fiscal 2026, up from $33.4 million in Q4 fiscal 2025 and $29.5 million in Q4 fiscal 2022.
Shareholder returns remain a priority: The company paid $4.5 million of dividends and repurchased approximately $0.6 million of common stock in Q4 fiscal 2026. Dividends per share increased from $0.26 in fiscal 2022 to $0.34 in recent fiscal 2026 quarters.
Liquidity appears adequate in the near term: At March 31, 2026, cash and equivalents were $103.7 million against $158.4 million of current liabilities, while current assets totaled $482.7 million. This implies a current ratio above 3.0.
Cash flow is highly dependent on working capital and noncash adjustments: Operating cash flow has ranged from $9.5 million to $40.4 million across the provided quarters, with changes in operating assets and liabilities sometimes consuming substantial cash.
Debt has increased substantially: Long-term debt rose from $199.7 million at March 31, 2022, to $472.8 million at March 31, 2026. The latest quarter also included a $50 million debt issuance, partly offset by $5 million of repayments.
Acquisition-related assets and leverage create balance-sheet risk: Goodwill and intangible assets increased from roughly $366 million in March 2022 to approximately $790 million in March 2026, while total liabilities reached $728.4 million. This leaves Standex more exposed to integration problems, impairment charges, and higher interest costs.

Overall, the statements point to stronger revenue growth and better underlying margins than Standex reported several years ago. The main issues for investors are the company’s elevated debt load, sizable acquisition-related goodwill and intangible assets, noncontrolling interests that can materially reduce earnings available to common shareholders, and the volatility of quarterly cash flow. Future performance will depend on whether Standex can convert its improved margins into consistent cash generation while reducing leverage.

08/23/26 03:40 PM ETAI Generated. May Contain Errors.

Standex International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Standex International's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

Standex International's net income appears to be on an upward trend, with a most recent value of $128.54 million in 2026, rising from $52.06 million in 2016. The previous period was $57.68 million in 2025. View Standex International's forecast to see where analysts expect Standex International to go next.

Standex International's total operating income in 2026 was $193.58 million, based on the following breakdown:

Total Gross Profit: $372.03 million
Total Operating Expenses: $178.45 million

Over the last 10 years, Standex International's total revenue changed from $751.59 million in 2016 to $891.60 million in 2026, a change of 18.6%.

Standex International's total liabilities were at $830.49 million at the end of 2026, a 0.4% increase from 2025, and a 159.1% increase since 2016.

In the past 10 years, Standex International's cash and equivalents has ranged from $88.57 million in 2017 to $195.71 million in 2023, and is currently $178.73 million as of their latest financial filing in 2026.

Over the last 10 years, Standex International's book value per share changed from 28.89 in 2016 to 62.34 in 2026, a change of 115.8%.

Related Companies

Financial statements for NYSE:SXI last updated on 8/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Standex International (SXI) Financials

Financials Breakdown Chart

Key Financial Trends

Standex International Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Standex International (SXI) Financials

Annual Income Statements for Standex International

Quarterly Income Statements for Standex International

Annual Cash Flow Statements for Standex International

Quarterly Cash Flow Statements for Standex International

Annual Balance Sheets for Standex International

Quarterly Balance Sheets for Standex International

Annual Metrics And Ratios for Standex International

Quarterly Metrics And Ratios for Standex International

Financials Breakdown Chart

Key Financial Trends

Standex International Financials - Frequently Asked Questions

When does Standex International's financial year end?

How has Standex International's net income changed over the last 10 years?

What is Standex International's operating income?

How has Standex International's revenue changed over the last 10 years?

How much debt does Standex International have?

How much cash does Standex International have?

How has Standex International's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools